Instinct Bio Technical Company Holdings Inc (BIOT)

$15.50 -2.61 (-14.41%)
Market Cap 291.81M
Revenue (ttm) 0.00
Net Income (ttm) -6.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 181,700
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 28.75M
Stochastic %K N/A
Beta -0.12
Analysts Strong Buy
Price Target N/A

Company Profile

Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. The company was founded in 2011 and is headquartered in Tokyo, Japan.

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
Tokyo, Japan
JamesMBMM
JamesMBMM Aug. 19 at 6:13 PM
$BIOT $FRGT 💥
0 · Reply
Tunacanman69
Tunacanman69 Aug. 19 at 4:30 PM
$BIOT these guys even released a PR saying they aren’t concerned with the price of their stock 😂. Just robbing everyone blind and then putting out a PR to rub it in our faces.
0 · Reply
Tunacanman69
Tunacanman69 Aug. 19 at 4:20 PM
$BIOT still can’t believe these dirt bag brothers robbed so many people in counsels
0 · Reply
Mintag6
Mintag6 Aug. 17 at 5:48 PM
$BIOT
0 · Reply
Lifefinder
Lifefinder Aug. 17 at 2:53 AM
$BIOT crazy this trap got people .. feel bad for many keep your heads up
1 · Reply
Bawee
Bawee Aug. 11 at 7:33 PM
$BIOT Ugly gotta feel for investors
0 · Reply
Bubae
Bubae Aug. 11 at 6:23 PM
$GYGY people complaining about insider dumping yet this ticker received a SEC notice of effect for the S-1 offering on July 28th. They had already filed three amendments by July 30th. Take a look at the chart for $BIOT which began trading on July 24th. That being said the "former " Chief Executive Officer and director held 65% and I'm sure that he knew that he held a losing hand with the pending S-1 offering in place. The filings https://www.sec.gov/edgar/browse/?CIK=2111846&owner=exclude https://www.sec.gov/Archives/edgar/data/2111846/000121390026083361/ea029987702-424b3_game.htm We are a “controlled company” under the Nasdaq listing rules because Nadir Ali, our former Chief Executive Officer and director, indirectly beneficially owns approximately 65% of the voting power of our outstanding common stock.
0 · Reply
JamesMBMM
JamesMBMM Aug. 11 at 8:49 AM
$BIOT And it might do it again
0 · Reply
yeeterminat0r
yeeterminat0r Aug. 7 at 7:46 PM
$BIOT monday $7
1 · Reply
blackmajic31
blackmajic31 Aug. 7 at 7:43 PM
$BIOT An actual green day....
0 · Reply
Latest News on BIOT
Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

Aug 10, 2026, 7:00 AM EDT - 9 days ago

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Jul 29, 2026, 10:28 AM EDT - 21 days ago

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement

Nov 12, 2025, 6:13 PM EST - 9 months ago

Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement

Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.

Sep 15, 2025, 9:30 AM EDT - 1 year ago

Relativity Acquisition Corp. Announces the Public Filing of a Registration Statement on Form F-4 for Instinct Bio Technical Company Inc.

Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment

Jan 4, 2023, 5:51 PM EST - 3 years ago

Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment

Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement

Jun 13, 2022, 8:06 AM EDT - 4 years ago

Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement

Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination

Jun 2, 2022, 8:58 PM EDT - 4 years ago

Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders to Approve Proposed Business Combination

Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

May 24, 2022, 9:13 AM EDT - 4 years ago

Biotech Acquisition Company Announces Submission of Prospectus Supplement to the Proxy Statement/Prospectus to The Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference

May 18, 2022, 9:01 AM EDT - 4 years ago

Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference

Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

May 16, 2022, 9:01 AM EDT - 4 years ago

Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

Biotech Acquisition Company and Blade Therapeutics, Inc. Announce Effectiveness of Registration Statement on Form S-4, Date of BAC's Extraordinary General Meeting to Approve Proposed Business Combination and Signing of Up to $75 million Committed Equity F

May 9, 2022, 6:10 PM EDT - 4 years ago

Biotech Acquisition Company and Blade Therapeutics, Inc. Announce Effectiveness of Registration Statement on Form S-4, Date of BAC's Extraordinary General Meeting to Approve Proposed Business Combination and Signing of Up to $75 million Committed Equity F

Biotech Acquisition Company Announces Filing of First Amendment to Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Apr 4, 2022, 3:49 PM EDT - 4 years ago

Biotech Acquisition Company Announces Filing of First Amendment to Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package

Apr 4, 2022, 8:00 AM EDT - 4 years ago

Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package

Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

Mar 24, 2022, 8:00 AM EDT - 4 years ago

Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference

Biotech Acquisition Company Announces Public Filing of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Mar 16, 2022, 8:00 AM EDT - 4 years ago

Biotech Acquisition Company Announces Public Filing of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Blade Therapeutics to Participate in Upcoming Investor Conferences

Mar 7, 2022, 8:00 AM EST - 4 years ago

Blade Therapeutics to Participate in Upcoming Investor Conferences

Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis

Jan 12, 2022, 8:00 AM EST - 5 years ago

Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis

Biotech Acquisition Company Announces Confidential Submission of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Jan 3, 2022, 8:00 AM EST - 5 years ago

Biotech Acquisition Company Announces Confidential Submission of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.

Blade Therapeutics Announces Positive Topline Data from Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

Nov 30, 2021, 8:00 AM EST - 5 years ago

Blade Therapeutics Announces Positive Topline Data from Phase 1 Clinical Study of Cudetaxestat, a Non-Competitive Autotaxin Inhibitor in Clinical Development for Idiopathic Pulmonary Fibrosis

JamesMBMM
JamesMBMM Aug. 19 at 6:13 PM
$BIOT $FRGT 💥
0 · Reply
Tunacanman69
Tunacanman69 Aug. 19 at 4:30 PM
$BIOT these guys even released a PR saying they aren’t concerned with the price of their stock 😂. Just robbing everyone blind and then putting out a PR to rub it in our faces.
0 · Reply
Tunacanman69
Tunacanman69 Aug. 19 at 4:20 PM
$BIOT still can’t believe these dirt bag brothers robbed so many people in counsels
0 · Reply
Mintag6
Mintag6 Aug. 17 at 5:48 PM
$BIOT
0 · Reply
Lifefinder
Lifefinder Aug. 17 at 2:53 AM
$BIOT crazy this trap got people .. feel bad for many keep your heads up
1 · Reply
Bawee
Bawee Aug. 11 at 7:33 PM
$BIOT Ugly gotta feel for investors
0 · Reply
Bubae
Bubae Aug. 11 at 6:23 PM
$GYGY people complaining about insider dumping yet this ticker received a SEC notice of effect for the S-1 offering on July 28th. They had already filed three amendments by July 30th. Take a look at the chart for $BIOT which began trading on July 24th. That being said the "former " Chief Executive Officer and director held 65% and I'm sure that he knew that he held a losing hand with the pending S-1 offering in place. The filings https://www.sec.gov/edgar/browse/?CIK=2111846&owner=exclude https://www.sec.gov/Archives/edgar/data/2111846/000121390026083361/ea029987702-424b3_game.htm We are a “controlled company” under the Nasdaq listing rules because Nadir Ali, our former Chief Executive Officer and director, indirectly beneficially owns approximately 65% of the voting power of our outstanding common stock.
0 · Reply
JamesMBMM
JamesMBMM Aug. 11 at 8:49 AM
$BIOT And it might do it again
0 · Reply
yeeterminat0r
yeeterminat0r Aug. 7 at 7:46 PM
$BIOT monday $7
1 · Reply
blackmajic31
blackmajic31 Aug. 7 at 7:43 PM
$BIOT An actual green day....
0 · Reply
spokes
spokes Aug. 6 at 7:21 PM
$BIOT WTF,this went from $50 to .41c in 10 days? how is this sh!t legal.
0 · Reply
SolomonSD
SolomonSD Aug. 5 at 8:55 PM
$BIOT this trash stock will do RS then gets delisted . They needed to raise 150$ million with equity so it’s possible we ll see it go to 0.10 cent soon ..
0 · Reply
bestdriver7
bestdriver7 Aug. 5 at 8:48 PM
$BIOT wow red zzz
0 · Reply
Tub66516
Tub66516 Aug. 3 at 11:09 PM
$BIOT 🐚 trash
0 · Reply
Cattitude
Cattitude Aug. 3 at 6:30 PM
$BIOT in for a swing at .42 🤷‍♀️
0 · Reply
Lifefinder
Lifefinder Aug. 3 at 4:53 PM
$BIOT what scam .. sorry to everyone that got the rug pulled
0 · Reply
23Benny
23Benny Aug. 3 at 6:56 AM
$BIOT $CSAI 🤣😂….not this one my friend…this is run by crooks criminals and frauds who ceo steals monye
0 · Reply
bestdriver7
bestdriver7 Aug. 3 at 2:03 AM
$BIOT .039?
0 · Reply
jimmy_sam001
jimmy_sam001 Aug. 2 at 8:03 PM
$BIOT how about $HUBC ?
0 · Reply
AlcoholicPenguin
AlcoholicPenguin Aug. 2 at 5:22 PM
$BIOT I watched one stock ipo run up to $50 then in one week it sold down to $5 then returned to $50 following week $CSAI
0 · Reply
Here4goodtimenotlongtime
Here4goodtimenotlongtime Aug. 1 at 10:04 PM
$BIOT POS that should bounce. Betting a steak dinner.
2 · Reply